GeoVax Reports 2017 Second Quarter Financial Results and Provides Corporate Update
ATLANTA, GA--(Marketwired - Aug 7, 2017) - GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines using its novel viral vector platform technology, announced its financial results for the quarter ended June 30, 2017, and …